SCHEMBL20737199

SCHEMBL20737199

c1ccc2c(c1)-c1ccccc1C21c2cc3ccccc3cc2-c2c1cc(-c1ccc(-c3cn4ccccc4n3)cc1)c1ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 13/20 0.45
▸ NPC1 O15118 12/20 0.45
▸ KDM4E B2RXH2 10/20 0.45
▸ PKM P14618 6/20 0.45
▸ EPHX2 P34913 1/20 0.45
▸ POLB P06746 3/20 0.44
▸ GFER P55789 3/20 0.44
▸ ALDH1A1 P00352 8/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ MIF P14174 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27250494 0.88 RAB9A (0.44) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20736934 0.86 RAB9A (0.42) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20736593 0.86 RAB9A (0.43) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20737194 0.85 ALDH1A1 (0.48) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL20736216 0.84 RAB9A (0.45) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20737148 0.83 RAB9A (0.48) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20737684 0.82 RAB9A (0.42) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL13789735 0.81 RAB9A (0.50) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20735968 0.80 RAB9A (0.45) RAB9ANPC1KDM4EPKMEPHX2
SCHEMBL20737248 0.79 ACACA (0.37) RAB9ANPC1KDM4EPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 RAB9A 1517/4885NPC1 1857/4885KDM4E 2169/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 RAB9A 1517/4885NPC1 1857/4885KDM4E 2169/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 RAB9A 1517/4885NPC1 1857/4885KDM4E 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback